Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis
Aim: Iron deficiency (ID) is associated with heart failure (HF) in a considerable proportion of patients. To improve the quality of life, lower the frequency of hospitalizations, and lower mortality rates of chronic HF patients (HF), this meta-analysis will look into the role of iron supplementation...
Saved in:
| Main Authors: | Burhanuddin Sohail Rangwala, Varisha Zuhair, Muhammad Saqlain Mustafa, Abdullah Mussarat, Aimen Waqar Khan, Fnu Danish, Syeda Mahrukh Fatima Zaidi, Faizan ur Rehman, Muhammad Ashir Shafique |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2024.2367956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience
by: Nikolina Brkić, et al.
Published: (2024-01-01) -
Effect of ferric carboxymaltose in the iron deficiency anemia patients undergoing cardiac surgery: A randomized clinical trial
by: Fateme Ramezani, et al.
Published: (2024-05-01) -
The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Inderbir Padda, et al.
Published: (2024-12-01) -
Patient with Secondary Amyloidosis Due to Crohn’s Disease on Hemodialysis Effectively Treated with Ferric Carboxymaltose Injections: A Case Report and Literature Review
by: Masayo Ueno, et al.
Published: (2025-04-01) -
Comparative Impact of Intravenous Iron Sucrose and Ferric Carboxymaltose on Hypophosphatemia and Anemia Parameters in Iron Deficiency Anemia: A Retrospective Study
by: Aslan S, et al.
Published: (2025-06-01)